Sakai Chemical Industry Co., Ltd. Announces Consolidated Financial Results for the Nine Months Ended December 31, 2019; and Provides Financial Guidance for the Year Ending March 31, 2020
February 06, 2020
Share
Sakai Chemical Industry Co., Ltd. announced consolidated financial results for the nine months ended December 31, 2019 . For the period, the company reported net sales of JPY 66,091 million against JPY 67,611 million a year ago. Operating income was JPY 3,122 million against JPY 3,548 million a year ago. Profit attributable to owners of parent was JPY 1,996 million against JPY 2,759 million a year ago. EPS were JPY 118.79 against JPY 159.86 a year ago.
The company also provided financial guidance for the year ending March 31, 2020. For the period the company expected net sales of JPY 90,000 million, operating income of JPY 3,500 million and Profit attributable to owners of parent of JPY 2,500 million and EPS of JPY 148.70.
SAKAI CHEMICAL INDUSTRY CO., LTD. is a Japan-based company principally manufactures and sells chemical industry products. The Company operates in two business segments. Chemical segment is involved in the manufacture and sale of chemical products. Main products include titanium products, resin additives, barium products, catalyst products, electronic materials, zinc products, functional materials, and other chemicals such as organophosphorus compounds, organic sulfur compounds, as well as water treatment agents, among others. Medical segment is involved in the manufacture and sale of pharmaceuticals and quasi drugs. Main products include barium X-ray contrast media, medical drugs for peptic ulcer & reflux esophagitis, general drugs such as cold and gastrointestinal drugs, functional foods, as well as other products such as medical devices, among others.
Sakai Chemical Industry Co., Ltd. Announces Consolidated Financial Results for the Nine Months Ended December 31, 2019; and Provides Financial Guidance for the Year Ending March 31, 2020
SAKAI CHEMICAL INDUSTRY CO., LTD. 
